176 related articles for article (PubMed ID: 14730504)
1. Parathyroid hormone: new assays, new receptors.
Martin KJ; Akhtar I; González EA
Semin Nephrol; 2004 Jan; 24(1):3-9. PubMed ID: 14730504
[TBL] [Abstract][Full Text] [Related]
2. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
3. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
Goodman WG
Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
[TBL] [Abstract][Full Text] [Related]
4. Biologic effects of parathyroid hormone metabolites: implications for renal bone disease.
Akhtar I; González EA
J Investig Med; 2004 Jan; 52(1):51-7. PubMed ID: 14989370
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy.
Goodman WG; Jüppner H; Salusky IB; Sherrard DJ
Kidney Int; 2003 Jan; 63(1):1-11. PubMed ID: 12472763
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone metabolites in renal failure: bioactivity and clinical implications.
Brossard JH; Yamamoto LN; D'Amour P
Semin Dial; 2002; 15(3):196-201. PubMed ID: 12100458
[TBL] [Abstract][Full Text] [Related]
7. Assays for parathyroid hormone and their use in patients with end-stage renal disease.
Goodman WG
Blood Purif; 2003; 21(1):118-23. PubMed ID: 12596757
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
9. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic regulation of circulating PTH: significance in health and in disease.
D'Amour P
Clin Biochem; 2012 Aug; 45(12):964-9. PubMed ID: 22569597
[TBL] [Abstract][Full Text] [Related]
11. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay.
Cantor T; Sci B
Nefrologia; 2003; 23 Suppl 2():69-72. PubMed ID: 12778858
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy.
Godber IM; Parker CR; Lawson N; Hitch T; Porter CJ; Roe SD; Cassidy MJ; Hosking DJ
Ann Clin Biochem; 2002 May; 39(Pt 3):314-7. PubMed ID: 12038608
[TBL] [Abstract][Full Text] [Related]
13. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor.
Divieti P; John MR; Jüppner H; Bringhurst FR
Endocrinology; 2002 Jan; 143(1):171-6. PubMed ID: 11751606
[TBL] [Abstract][Full Text] [Related]
14. New PTH assays and renal osteodystrophy.
Salusky IB; Jüppner H
Pediatr Nephrol; 2004 Jul; 19(7):709-13. PubMed ID: 15173936
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl-terminal parathyroid hormone fragments: biologic effects.
Scillitani A; Guarnieri V; Battista C; Chiodini I; Salcuni AS; Minisola S; Francucci CM; Carnevale V
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):23-6. PubMed ID: 21985976
[TBL] [Abstract][Full Text] [Related]
16. Influence of PTH assay methodology on differential diagnosis of renal bone disease.
Reichel H; Esser A; Roth HJ; Schmidt-Gayk H
Nephrol Dial Transplant; 2003 Apr; 18(4):759-68. PubMed ID: 12637646
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands.
Murray TM; Rao LG; Divieti P; Bringhurst FR
Endocr Rev; 2005 Feb; 26(1):78-113. PubMed ID: 15689574
[TBL] [Abstract][Full Text] [Related]
18. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
[TBL] [Abstract][Full Text] [Related]
19. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.
Andress DL; Endres DB; Maloney NA; Kopp JB; Coburn JW; Sherrard DJ
J Clin Endocrinol Metab; 1986 Nov; 63(5):1163-9. PubMed ID: 3760116
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone: what are we measuring and does it matter?
Blumsohn A; Al Hadari A
Ann Clin Biochem; 2002 May; 39(Pt 3):169-72. PubMed ID: 12038589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
